MacroGenics, Inc. (MGNX)
MGNX moved a median of -0.12% 30 minutes after news, and -0.05% by the close. How MGNX actually reacts to news — the realized, point-in-time move the market made, measured across 1,066 labeled events over the last three years with zero look-ahead.
MGNX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 48% | 1,064 |
| 30-min | -0.12% | 47% | 1,065 |
| 60-min | -0.14% | 46% | 1,065 |
| to close | -0.05% | 47% | 1,062 |
| Middle 50% of MGNX reactions | -1.09% to +1.23% |
|---|---|
| Median reaction (30-min) | -0.12% |
| Measured reactions | 1,066 |
Half of all MacroGenics, Inc. news events land between -1.09% and +1.23% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How MGNX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 25 | +2.45% | 56% | -2.17% |
| Analyst downgrades | 33 | +1.22% | 52% | 0.00% |
| Rating reiterations | 51 | +0.65% | 59% | -0.28% |
| Price-target cuts | 13 | -0.63% | 31% | -0.41% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how MGNX ranks against every other measured name →
That’s how MGNX usually reacts — get an email when it moves on news →Email me when MGNX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MGNX's baseline. Nothing else.
Recent MGNX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors | Press release | GlobeNewswire | -1.19% | -3.56% | |
| MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference | Press release | GlobeNewswire | -1.23% | -2.70% | |
| Form 8-K/A MACROGENICS INC For: Sep 03 | SEC filing · Form 8-K | SEC EDGAR | +0.71% | +4.76% | |
| Form S-8 MACROGENICS INC | SEC filing · Form S-8 | SEC EDGAR | +0.71% | +4.76% | |
| Form 10-Q MACROGENICS INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.43% | -3.56% | |
| Form 8-K MACROGENICS INC For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +8.48% | |
| MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position | Press release | GlobeNewswire | +0.00% | +8.48% | |
| MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program | Press release | GlobeNewswire | +1.13% | +1.26% | |
| Form 8-K MACROGENICS INC For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | -1.81% | -7.73% | |
| MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026 | Press release | GlobeNewswire | -1.81% | -7.73% | |
| Form 8-K MACROGENICS INC For: Jul 01 | SEC filing · Form 8-K | SEC EDGAR | +0.22% | -1.30% | |
| Form 8-K MACROGENICS INC For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | +0.85% | -0.64% | |
| MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals | Press release | GlobeNewswire | -0.22% | +2.17% | |
| MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval | Press release | GlobeNewswire | +4.59% | +2.63% | |
| Form 8-K MACROGENICS INC For: May 19 | SEC filing · Form 8-K | SEC EDGAR | +0.34% | -3.64% | |
| MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum | Press release | GlobeNewswire | +0.34% | +2.91% | |
| Form 10-Q MACROGENICS INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +1.14% | +15.56% | |
| Form 8-K MACROGENICS INC For: May 13 | SEC filing · Form 8-K | SEC EDGAR | +1.14% | +15.56% | |
| MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation | Press release | GlobeNewswire | +1.14% | +15.56% | |
| Form 8-K MACROGENICS INC For: May 11 | SEC filing · Form 8-K | SEC EDGAR | +1.74% | +2.03% | |
| MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals | Press release | GlobeNewswire | +1.74% | +2.03% | |
| Form 8-K MACROGENICS INC For: May 01 | SEC filing · Form 8-K | SEC EDGAR | +1.25% | -1.56% | |
| MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement | Press release | GlobeNewswire | +8.31% | +2.24% | |
| Form DEFA14A MACROGENICS INC | SEC filing · Form DEFA14A | SEC EDGAR | -0.29% | -7.29% | |
| FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study | Press release | GlobeNewswire | -2.01% | -1.43% | |
| Form 8-K MACROGENICS INC For: Apr 08 | SEC filing · Form 8-K | SEC EDGAR | -2.01% | -1.43% | |
| Form DEF 14A MACROGENICS INC For: May 19 | SEC filing · Form DEF | SEC EDGAR | -2.01% | -1.43% | |
| Form DEFA14A MACROGENICS INC | SEC filing · Form DEFA14A | SEC EDGAR | -2.01% | -1.43% | |
| Form 10-K MACROGENICS INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +12.19% | +41.74% | |
| Form 8-K MACROGENICS INC For: Mar 09 | SEC filing · Form 8-K | SEC EDGAR | +12.19% | +41.74% | |
| MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures | Press release | GlobeNewswire | +12.19% | +41.74% | |
| Form 8-K MACROGENICS INC For: Mar 02 | SEC filing · Form 8-K | SEC EDGAR | -1.60% | +1.06% | |
| MacroGenics to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | -1.01% | +0.51% | |
| Form 8-K MACROGENICS INC For: Feb 23 | SEC filing · Form 8-K | SEC EDGAR | +2.38% | +7.45% | |
| MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial | Press release | GlobeNewswire | +2.38% | +7.45% | |
| MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference | Press release | GlobeNewswire | -0.69% | +2.78% | |
| Form 8-K MACROGENICS INC For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | +0.36% | +2.19% | |
| Form 10-Q MACROGENICS INC For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.21% | — | |
| Form 8-K MACROGENICS INC For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | -1.21% | — | |
| MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress | Press release | GlobeNewswire | -1.21% | — | |
| MacroGenics to Participate in the Stifel 2025 Healthcare Conference | Press release | GlobeNewswire | -0.74% | +0.73% | |
| MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference | Press release | GlobeNewswire | +1.13% | +9.77% | |
| Form 10-Q MACROGENICS INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.25% | -1.25% | |
| Form 8-K MACROGENICS INC For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -1.25% | -1.25% | |
| Form S-8 MACROGENICS INC | SEC filing · Form S-8 | SEC EDGAR | -1.25% | -1.25% | |
| MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities | Press release | GlobeNewswire | -1.25% | -1.25% | |
| Form 8-K MACROGENICS INC For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +3.77% | +1.89% | |
| MacroGenics Appoints Eric Risser as President and Chief Executive Officer | Press release | GlobeNewswire | +3.77% | +1.89% | |
| Form 8-K MACROGENICS INC For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | -2.76% | -10.55% | |
| MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement | Press release | GlobeNewswire | -2.76% | -10.55% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MGNX section they belong to.
Where else MGNX is measured.
MGNX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Hill-Rom Holdings Inc (HRC) | 1,072 | +0.01% | 51% |
| MEDICINES (MDCO) | 1,068 | 0.00% | 48% |
| BioDelivery Sciences International, Inc. (BDSI) | 1,059 | 0.00% | 47% |
| Integer Holdings Corporation (ITGR) | 1,059 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is MacroGenics, Inc.'s median reaction calculated?
Every labeled MGNX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,066 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 47% of MGNX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MGNX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.